meglumine has been researched along with Arthropathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, MS; Kralik, SF; Ladd, LM; Singhal, KK | 1 |
| Nouh, MR; Ragatte, RR; Schweitzer, ME | 1 |
| Bittoun, J; Chevrot, A; Drapé, JL; Le Viet, D; Lecompte, M; Pessis, E; Resnick, D; Schnyder, P; Theumann, NH; Valenti, P | 1 |
| Andreisek, G; Duc, SR; Froehlich, JM; Hodler, J; Weishaupt, D | 1 |
| Adam, G; Casser, R; Günther, RW; Peiss, J; Urhahn, R | 1 |
| Chandnani, VP; Helgason, JW; Yu, JS | 1 |
| Sundaram, M | 1 |
| Beltran, J; Chandnani, V; Kursunoglu-Brahme, S; McGhee, RA | 1 |
2 review(s) available for meglumine and Arthropathies
| Article | Year |
|---|---|
MR arthrography: a review of current technique and applications.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Joints; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1997 |
Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Topics: Bone Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscular Diseases; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms; Spinal Diseases | 1991 |
6 other study(ies) available for meglumine and Arthropathies
| Article | Year |
|---|---|
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intra-Articular; Iopamidol; Joint Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2018 |
Contrast visibility for indirect MR arthrography with different protein contents and agent relaxivities at different field strengths: an in vitro model.
Topics: Albumins; Analysis of Variance; Contrast Media; Gadolinium; Heterocyclic Compounds; Image Enhancement; In Vitro Techniques; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Phantoms, Imaging; Protein Binding; Signal Processing, Computer-Assisted | 2011 |
MR imaging of the metacarpophalangeal joints of the fingers: evaluation of 38 patients with chronic joint disability.
Topics: Adolescent; Adult; Aged; Chronic Disease; Collateral Ligaments; Contrast Media; Female; Fingers; Follow-Up Studies; Humans; Image Enhancement; Imaging, Three-Dimensional; Joint Diseases; Magnetic Resonance Imaging; Male; Meglumine; Metacarpophalangeal Joint; Middle Aged; Observer Variation; Organometallic Compounds; Pain; Range of Motion, Articular; Retrospective Studies | 2005 |
MR arthrography of the shoulder, hip, and wrist: evaluation of contrast dynamics and image quality with increasing injection-to-imaging time.
Topics: Adolescent; Adult; Arthrography; Contrast Media; Female; Hip Joint; Humans; Injections, Intra-Articular; Joint Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Shoulder Joint; Wrist Joint | 2007 |
Gadopentetate-dimeglumine-enhanced MR imaging of osteonecrosis and osteochondritis dissecans of the elbow: initial experience.
Topics: Adolescent; Adult; Bone Marrow; Child; Contrast Media; Drug Combinations; Elbow Joint; Female; Gadolinium; Gadolinium DTPA; Humans; Humerus; Image Enhancement; Joint Diseases; Joint Loose Bodies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Osteochondritis Dissecans; Osteonecrosis; Pentetic Acid; Radiography; Radius | 1995 |
The use of gadolinium in the MR imaging of bone tumors.
Topics: Antineoplastic Agents; Bone Neoplasms; Contrast Media; Drug Combinations; Edema; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscle, Skeletal; Muscular Diseases; Necrosis; Neoplasm Staging; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 1997 |